Cirata Grants Share Options to Key Executives
Why we think this is neutral
This RNS announcement is a routine director dealings update, which does not contain any significant business or financial news. The granting of share options to key executives is a common practice and does not directly impact the company's operations or financial performance.
Key Points
- Cirata plc granted 560,000 options at an exercise price of 18.98p per share to its CFO, Ricardo Moura, and 350,000 options at 18.98p per share to its CRO, Dominic Arcari.
- The company also granted 50,000 options at an exercise price of 23.01p per share to its Legal Counsel, Gillian Shaw.
- The options are subject to vesting schedules, with 25% of Moura's options vesting on 31 December 2025 and the remaining 75% vesting on 31 December 2026. Arcari and Shaw's options have a 3-year vesting schedule.
Summary
The software company has granted share options to its Chief Financial Officer, Chief Revenue Officer, and Legal Counsel as part of their long-term incentive plans.
Cirata plc (LSE: CRTA) has announced the grant of share options to three of its persons discharging managerial responsibilities (PDMRs). The options were awarded under the company's 2025 Share Option Plan and are intended to align the interests of the leadership team with those of shareholders.
DIRECTOR DEALINGS